The Quigley Corporation to Host Conference Call to Review Third Quarter Results and Provide Company Update
November 11 2009 - 6:00AM
PR Newswire (US)
DOYLESTOWN, Pa., Nov. 11 /PRNewswire-FirstCall/ -- The Quigley
Corporation, (NASDAQ:QGLY), http://www.quigleyco.com/ today
announced it will host a conference call in which Ted Karkus,
Chairman and CEO, will provide a Company overview including a
review of activities, third quarter results and Q&A. The
conference call will be web cast live on The Quigley Corporation's
web site, (http://www.quigleyco.com/), at 11:00 AM (ET) on
Thursday, November 12, 2009. The Company will issue its third
quarter results at 8:30 AM (ET) that day. Participants wishing to
ask questions may access the live call by dialing (877) 217 - 6026.
A replay of the conference call will be available for 30 days on
the Company web site. About The Quigley Corporation The Quigley
Corporation (NASDAQ:QGLY) (http://www.quigleyco.com/) is a
diversified natural health medical science company. Its Cold Remedy
segment is a leading marketer and manufacturer of the Cold-EEZE®
family of lozenges and sugar free tablets clinically proven to
significantly reduce the severity and duration of the common cold.
Cold-EEZE® customers include leading national wholesalers and
distributors, as well as independent and chain food, drug and mass
merchandise stores and pharmacies. The Quigley Corporation has
several wholly owned subsidiaries including Quigley Manufacturing
Inc., which consists of an FDA approved facility to manufacture
Cold-EEZE® lozenges and fulfill other contract manufacturing
opportunities, and Quigley Pharma, Inc.,
(http://www.quigleypharma.com/), which conducts research in order
to develop and commercialize a pipeline of patented botanical and
naturally derived potential prescription drugs. Forward-Looking
Statements Certain statements in this press release are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 and involve known and
unknown risk, uncertainties and other factors that may cause the
Company's actual performance or achievements to be materially
different from the results, performance or achievements expressed
or implied by the forward-looking statement. Factors that impact
such forward-looking statements include, among others, changes in
worldwide general economic conditions, changes in interest rates,
government regulations, and worldwide competition. CONTACT: Ted
Karkus Investor Relations Chairman of the Board, CEO Carl Hymans
The Quigley Corporation G.S. Schwartz & Co. (215) 345-0919 ext.
114 212.725.4500 ext. 304 DATASOURCE: The Quigley Corporation
CONTACT: Ted Karkus, Chairman of the Board, CEO of The Quigley
Corporation, +1-215-345-0919 ext. 114; or Investor Relations: Carl
Hymans of G.S. Schwartz & Co., +1-212-725-4500 ext. 304, Web
Site: http://www.quigleyco.com/
Copyright
The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Oct 2024 to Nov 2024
The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about The Quigley (MM) (NASDAQ): 0 recent articles
More The Quigley (MM) News Articles